Neuromonitoring Devices Market Forecast to Boost Growth Globally During 2021-2030
Neuromonitoring equipment is very expensive and is only available to people who can afford it as a therapeutic option. This factor prevents the market from expanding. Moreover, due to the high cost of gadgets, some healthcare institutions in rural areas, such as small hospitals and dispensaries, cannot afford this expensive equipment for patient treatment.
According to a new report published by Allied Market Research, titled “Neuromonitoring Devices Market”, The neuromonitoring devices market was valued at $5.6 billion in 2021, and is estimated to reach $10.3 billion by 2030, growing at a CAGR of 7.24% from 2022 to 2030.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/16980
In order to provide advanced technical diagnosis to patients, healthcare professionals have chosen to use the latest technology in neuromonitoring devices, which has led to a significant growth in the market for neuromonitoring devices. In addition, the preference of patients and healthcare providers for wearable neuromongering equipment to avoid unnecessary hospital visits is expected to drive the market in the forecast period.
Impact Of Covid-19 on the Global Neuromonitoring Devices Market
The Covid-19 epidemic has had a negative impact on the market for neuromotor monitoring equipment. The high incidence of coronavirus infection has led to a decrease in the number of hospital visits and admissions of patients, which has led to a decline in the demand for neuromonitoring equipment.
Due to the high prevalence of viral infections and serious complications associated with the infection, healthcare professionals were forced to postpone several neurosurgeries, which negatively impacted the demand for neuromonitoring equipment.
With a high incidence of neurological diseases such as brain tumors, epilepsy and epilepsy in humans, the global market for neuromonitoring devices is expected to grow rapidly. Hospitalization and emergency department admissions have increased in recent years as the incidence of the disease has increased, leading to increasing demand for neuromonitoring equipment.
Key Market Players:
The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
The global market for neuromonitoring devices is divided by product and region. According to the product, the market is classified as Intracranial Pressure Monitoring, Cerebral Oximeter, Near-Infrared Spectroscopy, Spectral Imaging, Doppler Ultrasound, EEG, Fetal / Neonatal Neuromonitoring Equipment, Micro-Ultrasound and others. The fastest growing subdivision is expected in products near infrared spectroscopy.
